Cargando…
Characterizing Cellular Responses During Oncolytic Maraba Virus Infection
The rising demand for powerful oncolytic virotherapy agents has led to the identification of Maraba virus, one of the most potent oncolytic viruses from Rhabdoviridae family which displays high selectivity for killing malignant cells and low cytotoxicity in normal cells. Although the virus is readie...
Autores principales: | Hassanzadeh, Golnoush, Naing, Thet, Graber, Tyson, Jafarnejad, Seyed Mehdi, Stojdl, David F., Alain, Tommy, Holcik, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387032/ https://www.ncbi.nlm.nih.gov/pubmed/30700020 http://dx.doi.org/10.3390/ijms20030580 |
Ejemplares similares
-
Development and applications of oncolytic Maraba virus vaccines
por: Pol, Jonathan G, et al.
Publicado: (2018) -
Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential
por: Tong, Jessica G., et al.
Publicado: (2017) -
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
por: Pol, Jonathan G., et al.
Publicado: (2018) -
Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model
por: Dobson, Christine C, et al.
Publicado: (2016) -
Early and late neuropathological features of meningoencephalitis associated with Maraba virus infection
por: Maia-Farias, A., et al.
Publicado: (2020)